Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity.

Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity.

Accurate biomarkers of Mycobacterium tuberculosis infection activity would significantly improve early diagnosis, treatment and management of M. tuberculosis infection. We hypothesised that circulating B-lymphocytes may be useful biomarkers of tuberculosis (TB) infection status in highly TB-endemic...

Full description

Bibliographic Details
Main Authors:	Ismail Sebina, Irene A Biraro, Hazel M Dockrell, Alison M Elliott, Stephen Cose
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4156407?pdf=render

Similar Items

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
by: Irene Andia Biraro, et al.
Published: (2016-01-01)

Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort.
by: Irene A Biraro, et al.
Published: (2014-01-01)

Long-lived memory B-cell responses following BCG vaccination.
by: Ismail Sebina, et al.
Published: (2012-01-01)

Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda.
by: Ester Lilian Acen, et al.
Published: (2022-01-01)

Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.
by: Simon G Kimuda, et al.
Published: (2018-01-01)

Working together toward vaccines and biomarkers in the real world
by: Hazel M. Dockrell
Published: (2017-07-01)

Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.
by: Gyaviira Nkurunungi, et al.
Published: (2012-01-01)

Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in Uganda
by: Phillip Ssekamatte, et al.
Published: (2021-08-01)

Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
by: Behnaz Nateghi, et al.
Published: (2018-12-01)

Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.
by: Simon G Kimuda, et al.
Published: (2017-01-01)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
by: Lawrence Lubyayi, et al.
Published: (2020-05-01)

Feasibility and acceptability of undertaking postmortem studies for tuberculosis medical research in a low income country
by: Gift Ahimbisibwe, et al.
Published: (2023-12-01)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
by: Hazel M. Dockrell, et al.
Published: (2022-05-01)

Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme [version 2; peer review: 2 approved]
by: Damalie Nakanjako, et al.
Published: (2020-08-01)

Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme [version 1; peer review: 2 approved]
by: Damalie Nakanjako, et al.
Published: (2020-06-01)

CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.
by: Zahra Hasan, et al.
Published: (2009-12-01)

One Health - ‘joining the dots’
by: Hazel M. Dockrell
Published: (2012-06-01)

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
by: Susannah G. Ellsworth, MD, et al.
Published: (2022-09-01)

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.
by: Lalvani, A, et al.
Published: (1998)

B-lymphocyte-activating factor is a potential biomarker associated with susceptibility to Graves’ disease in Iraqi women
by: Hiba Y. Ibrahim, et al.
Published: (2023-11-01)

Dormancy antigens as biomarkers of latent tuberculosis infection
by: Irene Latorre, et al.
Published: (2015-08-01)

The circulating immune complexes as a biomarker of the endogenous intoxication in pulmonary tuberculosis
by: Evelina V. Lesnic, et al.
Published: (2022-07-01)

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
by: Paula Niewold, et al.
Published: (2023-07-01)

Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
by: Hector SM, et al.
Published: (2017-01-01)

Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells
by: Rose Nabatanzi, et al.
Published: (2018-03-01)

Measurement of circulating CD21−CD27− B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers
by: Alice Horisberger, et al.
Published: (2022-06-01)

Potential Circulating Biomarkers in Plasma of PNST Patients
by: Ignazio Gaspare Vetrano, et al.
Published: (2023-01-01)

Circulating Hsp70 Levels and the Immunophenotype of Peripheral Blood Lymphocytes as Potential Biomarkers for Advanced Lung Cancer and Therapy Failure after Surgery
by: Seyer Safi, et al.
Published: (2023-05-01)

Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
by: Phillip Ssekamatte, et al.
Published: (2023-01-01)

Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer
by: Ziyang Zeng, et al.
Published: (2023-01-01)

Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
by: Ennio Polilli, et al.
Published: (2021-08-01)

<it>Mycobacterium tuberculosis </it>PPD-induced immune biomarkers measurable <it>in vitro </it>following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
by: Worth Andrew, et al.
Published: (2010-07-01)

Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH
by: Davide Povero, et al.
Published: (2020-09-01)

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
by: Niewold, P, et al.
Published: (2023)

Circulating MicroRNA-29a: An Evolving Biomarker for Diagnosis of Pulmonary Tuberculosis
by: Jaya Garg, et al.
Published: (2021-03-01)

Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
by: Nathella Pavan Kumar, et al.
Published: (2016-01-01)

Circulating microRNAs in oncogenic viral infections: potential diagnostic biomarkers
by: Kinza Hasham, et al.
Published: (2020)

Cargoes of exosomes function as potential biomarkers for Mycobacterium tuberculosis infection
by: Nan Wang, et al.
Published: (2023-10-01)

Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
by: Haddow, L, et al.
Published: (2011)

Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome
by: Haddow, L, et al.
Published: (2011)